|Last Update: 05/17/13 - 4:04 PM EDT|
|YTD Performance: 32.02%|
|Previous Close: $165.95|
|52 Week Range: $100.91 - $168.76|
|Oustanding Shares: 212,609,362|
|Market Cap: 35,282,523,624|
|Qtr (06/13)||Qtr (09/13)||FY (09/13)||FY (09/14)|
|Number of Analysts||16||15||16||16|
|Growth Rate (Year over Year)||23.41%||15.50%||15.47%||12.02%|
Rather than trying to outguess the market, consider buying money managers directly.
Shares of BEN were upgraded to Buy from Neutral, said UBS. BEN's diversified product offering, global scale and local distribution is powerful. Price target goes to $185.
Shares of BEN were upgraded to Buy from Neutral, said Citigroup. Global Bond flows are sustainable, the U.S. business is undervalued and the equities business is performing best in class. Price target goes to $200.
BEN was downgraded to Neutral, Sterne Agee said. Valuation call, based on a $170 price target.
BEN estimates were boosted through 2014, Jefferies said. Company is leveraged to domestic equity market gains. Hold rating and new $155 price target.
BEN estimates increased through 2014, BMO Capital Markets said. Better than expected flows qtd. $154 price target and Market Perform rating.
These two companies pass muster with my guru strategies.
BEN was upgraded from Market Perform to Outperform, Keefe, Bruyette & Woods said. Valuation call, based on a $160 price target.
I'm glad to have reserves to put to work if the market falls 10% or 15%.